Adjuvant Lung Cancer Enrichment Marker Identification and Sequencing Trial (ALCHEMIST)
What is the purpose of this trial?
This research trial studies genetic testing in screening patients with stage IB-IIIA non-small cell lung cancer that has been or will be removed by surgery. Studying the genes in a patient's tumor cells may help doctors select the best treatment for patients that have certain genetic changes.
- Trial withNational Cancer Institute (NCI)
- Start Date06/01/2016
- End Date09/28/2021
- Last Updated07/15/2021
- Study HIC#1507016130